In vitro amoebicidal activity of propolis on Acanthamoeba castellanii

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 1, 2007, Pages 40-45

  Topalkara, Aysen ^a   Vural, Ayse ^a   Polat, Zubeyde ^a   Toker, Mustafa I ^a   Arici, Mustafa K ^a   Ozan, Fatih ^a   Cetin, Ali ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PROPOLIS;

ACANTHAMOEBA CASTELLANII; ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG EFFECT; DRUG SCREENING; IN VITRO STUDY; NONHUMAN; TROPHOZOITE;

ACANTHAMOEBA CASTELLANII; AMEBIASIS; AMEBICIDES; ANIMALS; ANTIPROTOZOAL AGENTS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CYSTS; PROPOLIS; TROPHOZOITES;

EID: 33947389186     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.0053     Document Type: Article

References (29)

1. Aksozek, A., McClellan, K., Howard, K., et al. Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J. Parasitol. 88:621-623, 2002.
2. Khan, N.A. Pathogenesis of Acanthamoeba infections. Microb. Pathog. 34:277-285, 2003.
3. Mattana, A., Biancu, G., Alberti, L., et al. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii. Antimicrob. Agents Chemother. 48:4520-4527, 2004.
4. Kilvington, S., Larkin, D.F., White, D.G., et al. Laboratory investigation of Acanthamoeba keratitis. J. Clin. Microbiol. 28:2722-2725, 1990.
5. Havsteen, B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96:67-202, 2002.
6. Sforcin, J.M., Fernandes, A., Jr., Lopes, C.A., et al. Seasonal effect on Brazilian propolis antibacterial activity. J. Ethnopharmacol. 73:243-249, 2000.
7. Kartal, M., Yildiz, S., Kaya, S., et al. Antimicrobial activity of propolis samples from two different regions of Anatolia. J. Ethnopharmacol. 86:69-73, 2003.
8. Walochnik, J., Obwaller, A., and Aspock, H. Correlations between morphological, molecular biological, and physiological characteristics in clinical and non-clinical isolates of Acanthamoeba spp. Appl. Environ. Microbiol. 66:4408-4413, 2000.
9. Schuster, F.L. Cultivation of pathogenic and opportunistic free-living amoebas. Clin. Microbiol. 15:342-354, 2002.
10. Sa-Nunes, A., Faccioli, L.H., and Sforcin, J.M. Propolis: Lymphocyte proliferation and IFN-gamma production. J. Ethnopharmacol. 87:93-97, 2003.
11. Marciano-Cabral, F., Puffenbarger, R., and Cabral, G.A. The increasing importance of Acanthamoeba infections. J. Eukaryot. Microbiol 47:29-36, 2000.
12. Karp, C.L., Tuli, S.S., Yoo, S.H., et al. Infectious keratitis after LASIK. Ophthalmology 110:503-510, 2003.
13. Dini, L.A., Cockinos, C., Frean, J.A., et al. Unusual case of Acanthamoeba polyphaga and pseudomonas aeruginosa keratitis in a contact lens wearer from Gauteng, South Africa. J. Clin. Microbiol. 38:826-829, 2000.
14. Schuster, F.L., and Visvesvara, G.S. Free-living amoebae as opportunistic and nonopportunistic pathogens of humans and animals. Int. J. Parasitol. 34:1001-1027, 2004.
15. Botton, E.J., Madayag, R.M., and Qureshi, M.N. Acanthamoeba keratitis: Synergy between amoebic and bacterial cocontaminants in contact lens care systems as a prelude to infection. J. Clin. Microbiol. 30:2447-2450, 1992.
16. Kilvington, S., and Larkin, D.F.P. Acanthamoeba adherence to contact lenses and removal by cleaning agents. Eye 4:589-590, 1990.
17. Hiti, K., Walochnik, J., Haller-Schober, E.M., et al. Viability of Acanthamoeba after exposure to a multipurpose disinfecting contact lens solution and two hydrogen peroxide systems. Br. J. Ophthalmol. 86:144-146, 2002.
18. Lloyd, D., Turner, N.A., Khunkitti, W., et al. Encystation in Acanthamoeba castellanii: development of biocide resistance. J. Eukaryot. Microbiol. 48:11-16, 2001.
19. Radford, C.F., Lehmann, O.J., Dart, J.K.G. Acanthamoeba keratitis: Multicentre survey in England, 1992-1996. Br. J. Ophthalmol. 82:1387-1392, 1998.
20. Duguid, I.G., Dart, J.K., Morlet, N., et al. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 104:1587-1592, 1997.
21. Ficker, L., Seal, D., Warhurst, D., et al. Acanthamoeba keratitis-resistance to medical therapy. Eye 4:835-838, 1990.
22. Kosrirukvongs, P., Wanachiwanawin, D., and Visvesvara, G.S. Treatment of Acanthamoeba keratitis with chlorhexidine. Ophthalmology 106:798-802, 1999.
23. Buck, S.L., Rosenthal, R.A., and Abshire, R.L. Amoebicidal activity of a preserved contact lens multipurpose disinfecting solution compared with a disinfection/neutralisation peroxide system. Cont. Lens Anterior Eye 21:81-84, 1998.
24. Kilvington, S., Hughes, R., Byas, J., et al. Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates. Antimicrob. Agents Chemother. 46:2007-2009, 2002.
25. Borazjani, R.N., and Kilvington, S. Efficacy of multipurpose solutions against Acanthamoeba species. Cont. Lens Anterior Eye. 28:169-175, 2005.
26. Marcucci, M.C. Propolis: Chemical composition, biological properties, and therapeutic activity. Apidologie 26:83-99, 1995.
27. Grange, J.M., and Davey, R.W. Antibacterial properties of propolis (bee glue). J. R. Soc. Med. 83:159-160, 1990.
28. Bosio, K., Avanzini, C., D'Avolio, A., et al. In vitro activity of propolis against Streptococcus pyogenes. Lett. Appl. Microbiol. 31:174-177, 2000.
29. Higashi, K.O., and de Castro, S.L. Propolis extracts are effective against Trypanosoma cruzi and have an impact on its interaction with host cells. J. Ethnopharmacol. 43:149-155, 1994.